Inspired nitric oxide and modulation of oxidative stress during cardiac surgery

Current Drug Safety

Volumn 4, Issue 3, 2009, Pages 188-198

  Elahi, Maqsood M ^a   Worner, Murray ^b   Khan, Jawad S ^a   Matata, Bashir M ^c  

^a PUNJAB INSTITUTE OF CARDIOLOGY   (Pakistan)

^b ST VINCENT S HOSPITAL   (Australia)

^c LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Chemiluminescence; Expired nitric oxide; Online measurement; Oxidative stress; Systemic inflammatory response

Indexed keywords

3 NITROTYROSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; INTERLEUKIN 8; LIPID PEROXIDE; NITRIC OXIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ADULT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CYTOKINE RELEASE; FEMALE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG GAS EXCHANGE; MALE; MEAN ARTERIAL PRESSURE; OXIDATIVE STRESS; PRIORITY JOURNAL; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; HEMODYNAMICS; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME;

ADMINISTRATION, INHALATION; AGED; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD-AIR BARRIER; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CYTOKINES; FEMALE; HEMODYNAMICS; HUMANS; INFLAMMATION MEDIATORS; LIPID PEROXIDES; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 73349128136     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488609789006958     Document Type: Article

References (47)

1. Schulze-Neick I, Li J, Penny DJ, Redington AN. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 2001; 121(6): 1033-9.
2. Troncy E, Hubert B, Pang D, et al. Pre-emptive and continuous inhaled NO counteracts the cardiopulmonary consequences of extracorporeal circulation in a pig model. Nitric Oxide 2006; 14(3): 261-71.
3. Gianetti J, Del Sarto P, Bevilacqua S, et al. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 2004; 127(1): 44-50.
4. Hofseth LJ, Saito S, Hussain SP, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 2003; 100: 143-8.
5. Langrehr JM, Hoffman RA, Lancaster JR, Simmons RL. Nitric oxide-a new endogenous immunomodulator. Transplantation 1993; 55: 1205-12.
6. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 1996; 93: 11853-8.
7. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298: 431-7.
8. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: 1424-37.
9. Rubbo H, Darley-Usmar V, Freeman BA. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 1996; 9: 809-20.
10. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. Biol Chem 1991; 266: 4244-50.
11. Szabo C, Ohshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1997; 1: 373-85.
12. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitriteinduced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-7.
13. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998; 356: 1-11.
14. Hinder F, Stubbe HD, Van Aken H, Waurick R, Booke M, Meyer J. Role of nitric oxide in sepsis associated pulmonary edema. Am J Respir Crit Care Med 1999; 159: 252-7
15. Hinder F, Meyer J, Booke J, et al. Endogenous NO and the pulmonary microvasculature in healthy sheep and during systemic inflammation. Am J Respir Crit Care Med 1998; 157: 1542-9.
16. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333: 214-21.
17. Traber DL. Presence and absence of nitric oxide synthase in sepsis. Crit Care Med 1996; 24: 1102-3.
18. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
19. Meyer J, Hinder F, Stothert J, et al. Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J Appl Physiol 1994; 76: 2785-93.
20. Geroulanos S, Schilling J, Cakmakci M, Jung HH, Largiader F. Inhibition of NO synthesis in septic shock. Lancet 1992; 339: 435.
21. Dellinger RP, Zimmerman JL, Taylor RW, et al. Inhaled Nitric Oxide in ARDS Study Group. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998; 26 (1): 15-23.
22. Taylor RW, Zimmerman JL, Dellinger RP, et al. Inhaled Nitric Oxide in ARDS Study Group. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291 (13): 1603-9.
23. El Kebir D, Hubert B, Taha R, et al. Effects of inhaled nitric oxide on inflammation and apoptosis after cardiopulmonary bypass. Chest 2005; 128 (4): 2910-7.
24. Marczin N, Riedel B, Royston D, Yacoub M. Intravenous nitrate vasodilators and exhaled nitric oxide. Lancet 1997; 349: 1742.
25. Minami Y, Liu R, Ishibe Y, Okazaki N, Funakoshi T, Ueda K. Evaluation of exhaled nitric oxide in thoracic surgery patients under one lung ventilation using a newly designed online exhaled nitric oxide measuring system. Yonago Acta Med 2003; 46: 133-44
26. Arieli R, Van Liew HD. Correction for the response, time and, delay of mass spectrometers. J Appl Physiol 1981; 51: 1417-22.
27. Nourooz-Zadeh J, Tjaddini-Sarmadi J, Wolf SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994; 220: 403-9.
28. Khan J, Brennan DM, Bradley N, Gao B, Bruckdoefer R, Jacobs M. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J 1998; 399: 795-801.
29. Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T. Augmented oxidative stress of platelets in chronic smokers: mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability. J Am Coll Cardiol 2001; 38: 1320-7.
30. Yii M, Gourlay T, Fleming J, Matata B, Taylor KM. Evaluation of Carmeda Bioactive Surface (CBAS), Duraflo II and a novel non-specific protease-modified surface using a new in vitro model simulating cardiopulmonary bypass. Perfusion 1996; 11: 229-40.
31. Kovesi T, Royston D, Yacoub M, Marczin N. Basal and nitroglycerin-induced exhaled nitric oxide before and after cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2003; 90, 608-16.
32. Al-Ruzzeh S, Hoare G, Marczin N, et al. Off-pump coronary artery bypass surgery is associated with reduced neutrophils activation as measured by the expression of CD11b: a prospective randomized study. Heart Surg Forum 2003; 6, 89-93.
33. Onorati F, De Feo M, Mastroroberto P, et al. Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg 2005; 79: 837-45.
34. Mathru M, Huda R, Solanki DR, Hays S, Lang JD. Inhaled nitric oxide attenuates reperfusion inflammatory responses in humans. Anesthesiology 2007; 107 (4): 677-8.
35. Cannon RO III, Schechter AN, Panza JA, et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 2001; 108: 279-87.
36. Pearlstein DP, Ali MH, Mungai PT, Hynes KL, Gewertz BL, Schumacker PT. Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler Thromb Vasc Biol 2002; 22, 566-73.
37. Ishibe Y, Liu R, Ueda M, Mori K, Miura N. Role of inhaled nitric oxide in ischaemia-reperfusion injury in the perfused rabbit lung. Br J Anaesth 1999; 83: 430-5.
38. Bruda NL, Hurlbert BJ, Hill GE. Aprotinin reduces nitric oxide production in vitro and in vivo in a dose dependent manner. Clin Sci Colch 1998; 94, 505-9.
39. Pietropaoli AP, Perkins PT, Perillo IB, Hyde RW. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans. Am J Respir Crit Care Med 2000; 161: 2113-4.
40. Cremona G, Higenbottam T, Takao M, Hall L, Bower EA. Exhaled nitric oxide in isolated pig lungs. J Appl Physiol 1995; 78: 59-63.
41. Persson MG, Zetterstrom O, Agrenius V, Ihre E, Gustafsson LE. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994; 343: 146-7.
42. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995; 92: 7809-13.
43. Belvisi M, Barnes PJ, Larkin S, et al. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol 1995; 283: 255-8.
44. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-5.
45. Marczin N, Antonov A, Papapetropoulos A, et al. Monocytesinduced downregulation of nitric oxide synthase in cultured aortic endothelial cells. Arterioscler Thromb Vasc Biol 1996; 16: 1095-103.
46. Sartori C, Lepori M, Busch T, et al. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans. Am J Respir Crit Care Med 1999; 160: 879-82.
47. Cuthberson BH, Galley HF, Webster NR. Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med 2000; 28 (6): 1736-41.